Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
6 Patents
#667 in San Francisco, CA
#10,578 in California
#45,007 in US
Triact Therapeutics, Inc.
Forward Citations = 4
5 inventors:
San Francisco, CA, United States of America
Triact Therapeutics, Inc.
% Expired Patents = 16.7
Forward Citations = 4
Loading Chart...
Loading Chart...
5 inventors (with patents filed for the assignee):
Thomas F White (6 out of 7 patents)
Dan Hoth (2 out of 2 patents)
Steven A Smith (1 out of 5 patents)
4. Edward F Schnipper (1 out of 16 patents)
5. Stephen M Nava (1 out of 1 patent)
6 patents:
Company Overview
Triact Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for neurological disorders. Our proprietary drug discovery platform enables us to rapidly identify and advance novel drug candidates. We are committed to improving the lives of patients with unmet medical needs through the development of breakthrough treatments.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Triact Therapeutics, Inc.. Retrieved from https://idiyas.com/company/triact-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]